🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial compares the effect of teclistamab and pomalidomide ...
Status
Recruiting
Location
ECOG-ACRIN Cancer Research Group
Start Date
2027-04-12
Trial ID
NCT07463807
This phase III trial compares standard chemotherapy to therapy with liposom...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-07-21
Trial ID
NCT04293562
Treatments Being Tested
This clinical trial studies diffusion-weighted magnetic resonance imaging (...
Status
Withdrawn
Location
Virginia Commonwealth University Massey Cancer Center
Start Date
2014-07
Trial ID
NCT02059889
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Universitair Medisch Centrum St. Radboud - Nijmegen
Start Date
2006-10
Trial ID
NCT00433433
Treatments Being Tested
The main objective of this study is to make a first evaluation of the relat...
Status
Completed
Location
CHRU de Montpellier - Hôpital Gui de Chauliac
Start Date
2016-01-29
Trial ID
NCT02329626
Treatments Being Tested
This phase II trial compares mosunetuzumab to the usual treatment (rituxima...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2024-01-23
Trial ID
NCT05886036
RATIONALE: Measuring changes in glucose metabolism in patients with cancer ...
Status
Completed
Location
Jonsson Comprehensive Cancer Center at UCLA
Start Date
2004-12
Trial ID
NCT00450567
Treatments Being Tested
This phase I trial studies the side effects and the best dose of stereotact...
Status
Terminated
Location
Stanford University
Start Date
2012-04
Trial ID
NCT01494012
RATIONALE: Diagnostic procedures using fludeoxyglucose F 18 and a surgical ...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-07-16
Trial ID
NCT00732563
This phase I trial investigates the side effects and best dose of peposerti...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2021-12-20
Trial ID
NCT04533750